Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring SystemsPRNewsWire • 06/10/24
Cadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance of Anticoagulation Quality in LVAD PatientsPRNewsWire • 06/03/24
Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for May 2024InvestorPlace • 05/28/24
Appriss Retail Names Industry Veteran and Innovator Dean Abbott Chief Data ScientistBusiness Wire • 05/02/24
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the KneePRNewsWire • 04/29/24